Trial Profile

Comparison of the healing effect of Vonoprazan and Lansoprazole in ulcer after gastric endoscopic submucosal dissection: A prospective, randomized controlled trial

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 18 Jul 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

05 Jun 2018 Results presented at the Digestive Disease Week 2018
12 Feb 2018 Primary endpoint (Shrinkage ratio of the ESD-induced artificial ulcers at 4 and 8 weeks post-ESD) has not been met, as per the results published in the Digestive Diseases and Sciences.
12 Feb 2018 Primary endpoint (gastric ulcer healing rate of post-ESD ulcers after four and eight weeks of gastric ESD) has not been met, as per the results published in the Digestive Diseases and Sciences.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com